Point72 Hong Kong LTD Dyne Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.36 - $10.5 $1,979 - $4,767	-454 Reduced 77.47%	132 $1,000
Q1 2022 May 16, 2022	BUY	$6.52 - $12.27 $3,820 - $7,190	586 New	586 $6,000
Q4 2021 Feb 14, 2022	SELL	$11.89 - $16.07 $27,442 - $37,089	-2,308 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$15.6 - $21.46 $36,004 - $49,529	2,308 New	2,308 $37,000

210

102M

234K

238K

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.55B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.